One of the most common questions women have when becoming pregnant after 35 is about prenatal testing. Which tests are recommended? What do they screen for? And how do you decide which options are right for you? These are important questions, and the good news is that there is a well-established range of screening and diagnostic options available today that can help provide information and reassurance during pregnancy.
This article offers an overview of the prenatal testing landscape for women over 35, drawing on current guidelines from obstetric and medical organizations. The goal is to help you understand your options so you can have well-informed conversations with your OB/GYN or midwife — not to recommend any specific testing path, which should be individualized to your circumstances and preferences.
Why Testing Options May Be Discussed More After 35
The term “advanced maternal age” — typically defined as being 35 or older at the time of delivery — is associated with a slightly higher statistical likelihood of certain chromosomal variations in pregnancy, including Down syndrome (trisomy 21), trisomy 18, and trisomy 13. This is primarily related to age-related changes in egg quality rather than anything specific to individual health.
According to the American College of Obstetricians and Gynecologists (ACOG), all pregnant women — regardless of age — should be offered both screening and diagnostic testing options. The emphasis has shifted from age-based recommendations to informed patient choice, meaning your preferences and values play a central role in deciding what testing, if any, is right for you.
It is also worth noting that the vast majority of pregnancies after 35 — and even in the early 40s — do not involve chromosomal differences. Increased statistical risk is not the same as certainty, and each pregnancy is unique.
Screening Tests: What They Can and Cannot Tell You
Screening tests are designed to assess the probability that a pregnancy may involve certain chromosomal or structural variations. They do not provide a diagnosis — rather, they indicate whether further diagnostic testing might be appropriate based on risk assessment.
Cell-Free DNA Screening (NIPT)
Non-invasive prenatal testing (NIPT) analyzes fragments of fetal DNA found in maternal blood and can screen for the most common chromosomal conditions with relatively high sensitivity and specificity. It is typically offered from around 10 weeks of pregnancy. Results are reported as high-risk or low-risk rather than as a diagnosis, and a high-risk result should always be followed up with diagnostic testing before any decisions are made. NIPT can also screen for sex chromosome variations and, in some panels, other chromosomal differences.
First Trimester Combined Screening
This approach combines a nuchal translucency ultrasound (which measures fluid at the back of the baby’s neck) with blood tests measuring specific proteins (PAPP-A and free beta-hCG). Together, these provide a risk estimate for certain chromosomal conditions. It is typically performed between 11 and 13 weeks. Detection rates and false-positive rates vary and are discussed in detail on the ACOG website.
Second Trimester Quad Screen
The quad screen measures four markers in maternal blood and is typically performed between 15 and 20 weeks. It can screen for Down syndrome, trisomy 18, neural tube defects, and abdominal wall defects. It may be used on its own or in combination with first trimester screening.
Understanding the difference between screening and diagnostic tests is important context if you are navigating these decisions. For a broader overview of pregnancy after 35, exploring resources on what to expect during pregnancy after 35 may be helpful.
Diagnostic Tests: More Definitive Information
Unlike screening tests, diagnostic tests can provide a definitive answer about whether a chromosomal difference is present. They carry a small procedural risk and are typically offered when a screening result is high-risk, or when a woman chooses to pursue diagnostic information directly.
Chorionic Villus Sampling (CVS)
CVS involves taking a small sample of placental tissue, typically between 10 and 13 weeks of pregnancy. It can provide chromosomal analysis and in some cases gene-specific testing. The procedure carries a small risk of pregnancy loss — typically cited as less than 1% in experienced hands, though rates vary by provider and institution.
Amniocentesis
Amniocentesis involves taking a small sample of amniotic fluid, typically between 15 and 20 weeks. It can analyze fetal chromosomes and, depending on what is being tested for, specific genetic conditions. Like CVS, it carries a small procedural risk of pregnancy loss. It is considered the gold standard for chromosomal diagnosis during pregnancy.
Structural Ultrasound: The Anatomy Scan
Separate from chromosomal screening, the mid-pregnancy anatomy scan (typically performed around 18–20 weeks) provides a detailed look at fetal anatomy and development. It can identify many structural differences that may need monitoring or intervention, and is recommended for all pregnancies regardless of age.
Some women over 35 may also be offered additional ultrasounds to monitor growth and placental function, though recommendations for additional surveillance vary based on individual risk factors and clinical judgment.
Making Decisions About Prenatal Testing
There is no single right answer about which tests to pursue. Some women want as much information as possible; others prefer to minimize intervention; still others make decisions based on what they would do with certain information. All of these approaches are valid, and your healthcare provider should support your informed choices rather than prescribe a specific path.
Genetic counselors — specialists trained in helping people understand genetic testing and results — can be an invaluable resource when navigating these decisions. Many maternal-fetal medicine practices offer genetic counseling alongside testing.
If you are thinking about the emotional aspects of navigating pregnancy decisions after 35, resources on emotional wellbeing during pregnancy after 35 may offer helpful perspective.
Frequently Asked Questions
Is prenatal testing mandatory after 35?
No. Current ACOG guidelines emphasize that all women should be offered both screening and diagnostic testing options, but participation is entirely voluntary. The decision about which tests to pursue — or whether to pursue any — is yours to make in consultation with your healthcare provider.
What is the difference between NIPT and amniocentesis?
NIPT is a screening test — it assesses probability using fetal DNA in maternal blood and carries no procedural risk to the pregnancy. Amniocentesis is a diagnostic test — it examines fetal chromosomes directly from amniotic fluid and can provide a definitive result, but involves a small procedural risk. A positive NIPT result should generally be confirmed with a diagnostic test before any decisions are made.
Can prenatal tests screen for everything?
No. Current prenatal tests screen for a defined range of chromosomal and some genetic conditions, but they cannot identify all possible health differences. An unaffected result on a screening panel does not guarantee that all conditions have been excluded. Your provider can explain what specific tests screen for and what they cannot detect.
Will my insurance cover prenatal testing after 35?
Coverage varies significantly by insurance plan and location. Some insurers cover standard prenatal screening for all pregnancies; others have age or risk-based criteria. It is worth contacting your insurer before testing to understand what is covered and what your out-of-pocket costs may be.
Key Takeaways
- Current ACOG guidelines offer all pregnant women, regardless of age, the option of both screening and diagnostic prenatal tests.
- Screening tests (like NIPT and the quad screen) assess probability — they are not diagnoses and should be interpreted with care.
- Diagnostic tests (CVS and amniocentesis) provide definitive chromosomal information but carry a small procedural risk.
- There is no single “right” testing approach — decisions should reflect your individual values, preferences, and clinical circumstances.
- Genetic counselors can be a valuable resource for understanding your options and interpreting results.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.